139 related articles for article (PubMed ID: 31806587)
1. A case of concurrent psoriasis and ulcerative colitis with development of arthritis during adalimumab treatment.
Toyama S; Kanda H; Tateishi S; Yamada A; Sato S; Asano Y
Eur J Dermatol; 2019 Dec; 29(6):651-653. PubMed ID: 31806587
[No Abstract] [Full Text] [Related]
2. Case of psoriasis vulgaris developing ulcerative colitis during adalimumab treatment.
Nakamura K; Asano Y; Shibata S; Nakao M; Shida R; Takahashi T; Mitsui A; Araki M; Yamada A; Sato S
J Dermatol; 2015 Oct; 42(10):1029-30. PubMed ID: 26111055
[No Abstract] [Full Text] [Related]
3. Guillain-Barré syndrome in a patient on adalimumab for the treatment of psoriasis.
Natividade NB; Felix PAO; Lerer C
An Bras Dermatol; 2017; 92(5 Suppl 1):85-87. PubMed ID: 29267456
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical ulcerative colitis during adalimumab treatment of psoriasis resolved by switch to ustekinumab.
Kolios AGA; Biedermann L; Weber A; Navarini AA; Meier J; Cozzio A; French LE
Br J Dermatol; 2018 Feb; 178(2):551-555. PubMed ID: 28477389
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium marinum infection contracted from seaweed wrap in a psoriasis patient undergoing treatment with adalimumab.
Timoney I; Lynch M; Timoney L; Feeney E; Kirby B
Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469748
[TBL] [Abstract][Full Text] [Related]
6. Adalimumab-Receiving Ulcerative Colitis Patient Suffered Latent Tuberculosis Reactivation Despite Correct Chemoprophylaxis and was Successfully Treated while on Anti-Tumour Necrosis Factor Therapy.
Agudo B; Díaz G; González-Lama Y
J Crohns Colitis; 2016 Dec; 10(12):1453-1454. PubMed ID: 27215554
[No Abstract] [Full Text] [Related]
7. Concurrent development of psoriatic arthritis, drug-induced interstitial pneumonia, and increased anti-nuclear antibodies in a patient with psoriasis vulgaris undergoing adalimumab treatment.
Yasuda M; Morimoto N; Yonemoto Y; Sunaga N; Ishikawa O
Eur J Dermatol; 2019 Feb; 29(1):81-82. PubMed ID: 30530442
[No Abstract] [Full Text] [Related]
8. Successful adalimumab treatment of a psoriasis vulgaris patient with hemodialysis for renal failure: A case report and a review of the previous reports on biologic treatments for psoriasis patients with hemodialysis for renal failure.
Kusakari Y; Yamasaki K; Takahashi T; Tsuchiyama K; Shimada-Omori R; Nasu-Tamabuchi M; Aiba S
J Dermatol; 2015 Jul; 42(7):727-30. PubMed ID: 25916786
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of a granulomatous mastitis and aseptic osteitis after anti-TNF therapy in a patient with pustular psoriasis.
Garraud T; Barbarot S; Berthelot JM; Le Goff B
Joint Bone Spine; 2016 Jan; 83(1):107-8. PubMed ID: 26054447
[No Abstract] [Full Text] [Related]
10. Small-Fiber Neuropathy in a Pediatric Patient Following Anti-Tumor Necrosis Factor-α Therapy for Ulcerative Colitis.
Breton J; Ellazam B; Haddad E; Deslandres C
J Pediatr Gastroenterol Nutr; 2018 Jun; 66(6):e159-e161. PubMed ID: 29620599
[No Abstract] [Full Text] [Related]
11. Adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature.
Piaserico S; Dapavo P; Conti A; Gisondi P; Russo FP
J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1853-1859. PubMed ID: 28146345
[TBL] [Abstract][Full Text] [Related]
12. Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or Psoriasis.
Ryan C; Sobell JM; Leonardi CL; Lynde CW; Karunaratne M; Valdecantos WC; Hendrickson BA
Am J Clin Dermatol; 2018 Jun; 19(3):437-447. PubMed ID: 29380251
[TBL] [Abstract][Full Text] [Related]
13. Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
Sands BE; Peyrin-Biroulet L; Loftus EV; Danese S; Colombel JF; Törüner M; Jonaitis L; Abhyankar B; Chen J; Rogers R; Lirio RA; Bornstein JD; Schreiber S;
N Engl J Med; 2019 Sep; 381(13):1215-1226. PubMed ID: 31553834
[TBL] [Abstract][Full Text] [Related]
14. Multifocal motor neuropathy following treatment with adalimumab for ulcerative colitis.
Fionda L; Vanoli F; Di Pasquale A; Leonardi L; Morino S; Antonini G
J Neurol; 2018 Jun; 265(6):1466-1468. PubMed ID: 29767352
[No Abstract] [Full Text] [Related]
15. SB5: An Adalimumab Biosimilar.
Frampton JE
BioDrugs; 2018 Oct; 32(5):507-510. PubMed ID: 30251234
[TBL] [Abstract][Full Text] [Related]
16. Review of Biosimilars of Adalimumab.
Kaushik VV
J Assoc Physicians India; 2017 May; 65(5 Suppl):15-21. PubMed ID: 28836746
[TBL] [Abstract][Full Text] [Related]
17. Successful Use of Adalimumab for Treating Pyoderma Gangrenosum with Ulcerative Colitis under Corticosteroid-tapering Conditions.
Sagami S; Ueno Y; Tanaka S; Nagai K; Hayashi R; Chayama K
Intern Med; 2015; 54(17):2167-72. PubMed ID: 26328641
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients.
Iborra M; Pérez-Gisbert J; Bosca-Watts MM; López-García A; García-Sánchez V; López-Sanromán A; Hinojosa E; Márquez L; García-López S; Chaparro M; Aceituno M; Calafat M; Guardiola J; Belloc B; Ber Y; Bujanda L; Beltrán B; Rodríguez-Gutiérrez C; Barrio J; Cabriada JL; Rivero M; Camargo R; van Domselaar M; Villoria A; Schuterman HS; Hervás D; Nos P;
J Gastroenterol; 2017 Jul; 52(7):788-799. PubMed ID: 27722996
[TBL] [Abstract][Full Text] [Related]
19. Adalimumab: A Review in Chronic Plaque Psoriasis.
Burness CB; McKeage K
Drugs; 2015 Dec; 75(18):2119-30. PubMed ID: 26586242
[TBL] [Abstract][Full Text] [Related]
20. The development of chronic inflammatory demyelinating polyneuropathy during adalimumab treatment in a patient with psoriasis vulgaris.
Nakao M; Asano Y; Nakamura K; Shida R; Takahashi T; Yoshizaki A; Mitsui A; Shibata S; Araki M; Watanabe R; Ikawa Y; Toyoda C; Oka H; Sato S
Eur J Dermatol; 2016 Aug; 26(4):404-5. PubMed ID: 27086491
[No Abstract] [Full Text] [Related]
[Next] [New Search]
